Dexcom in the news

DexCom's stock dropped due to profit-taking before its next earnings report, despite positive recent performance and analyst ratings, while insider selling and mixed institutional interest were noted.

Dexcom launched the fifth season of its Dexcom U NIL program, expanding its roster of college athletes with diabetes and highlighting research that shows the program's positive impact on confidence and reducing stigma.

Dexcom U enters its fifth season with a record roster, indicating a decline in diabetes stigma among young athletes.

Dexcom launched its largest Dexcom U program to date, supporting college athletes with diabetes, while its stock is considered modestly undervalued with strong fundamentals despite some insider selling.

San Diego FC and Right to Dream will host the inaugural Right to Dream Cup, presented by Dexcom, for youth players from October 10-11.

DexCom's stock increased by 1.22% as it prepares to report Q3 2026 earnings on October 29, with analysts anticipating further growth following strong Q2 results and raised full-year guidance.

Dexcom's stock dropped slightly after RBC Capital raised its price target to USD 105, following strong Q2 2026 earnings and expansion into Type 2 diabetes.

ShinyHunters listed O'Reilly Automotive and Dexcom on a new dark web leak site, threatening to publish corporate data, with Dexcom's breach potentially exposing sensitive health information.

DexCom shows strong fundamental growth and profitability, paired with a constructive technical setup characterized by consolidation within a positive long-term trend.

Dexcom faces 11 lawsuits from Morgan & Morgan, alleging G7 continuous glucose monitor malfunctions caused severe medical emergencies and deaths, primarily in children.

DexCom's report reveals gaps in Type 2 diabetes CGM awareness and access, highlighting growth opportunities with GLP-1 medications and reinforcing the need for broader adoption.

Heidi launched AI agents for administrative tasks in healthcare, Dexcom expanded its partnership with Health2Sync for CGM data integration, and QUT received a grant for AI launchpads in health.

RBC has raised its price target for DexCom to $105 from $90, keeping an Outperform rating.

ShinyHunters claimed data breaches at O'Reilly Automotive and Dexcom, threatening to publish stolen data by Friday if the companies do not respond.

DexCom's EVP Sadie Stern sold 2,565 shares of company stock for $86.15 per share under a preset trading plan.

Dexcom published its 2026 "State of Type 2 Report" revealing critical opportunities in global diabetes care, and partnered with Team Novo Nordisk to advance Type 1 diabetes care.

DexCom's report identifies significant gaps in CGM awareness and access for Type 2 diabetes patients, signaling growth opportunities linked to GLP-1 medication use and policy changes.

Dexcom's report reveals significant barriers in access, awareness, and education surrounding continuous glucose monitoring for type 2 diabetes, despite its proven benefits for condition management.

Dexcom's 2026 report reveals a significant opportunity to expand continuous glucose monitoring technology access and awareness for Type 2 diabetes management.

Dexcom, a continuous glucose monitoring leader, re-partners with Team Novo Nordisk, the all-diabetes professional cycling team, for a multi-year deal starting in 2027.